CORONA, Calif., Sept. 13 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI - News), a leading specialty pharmaceutical company, announced today that it has reached a settlement with Unimed Pharmaceuticals, Inc., a wholly owned subsidiary of Solvay Pharmaceuticals, Inc., and Laboratories Besins Iscovesco on outstanding patent litigation related to AndroGel® 1% (testosterone gel) CIII, a topical testosterone replacement gel.
